PONTWING

Welcome to the Brand page for “PONTWING”, which is offered here for Recombinant monoclonal antibody directed against cd 20, for disease testing and medical treatment use;pontwing; pont wing;.

Its status is currently believed to be active. Its class is unavailable. “PONTWING” is believed to be currently owned by “Laboratoire Français; du Fractionnementet des Biotechnologies”.


Owner:
LABORATOIRE FRANÇAIS; DU FRACTIONNEMENTET DES BIOTECHNOLOGIES
Owner Details
Description:
Recombinant monoclonal antibody directed against CD 20, for disease testing and medical treatment use;PONTWING; PONT WING;
Categories: RECOMBINANT MONOCLONAL ANTIBODY DIRECTED AGAINST